National ALS Clinic and Research Group, Beaumont Hospital Dublin/Academic Unit of Neurology

Trinity College Dublin

The National ALS Clinic and Research Group based at Beaumont Hospital Dublin provides a multidisciplinary service to the entire Irish ALS population.

 

Trinity College Dublin

The National ALS Clinical and Research Group undertakes research in epidemiology, cognition, genetics, bioinformatics, drug development and novel biomarker development, and commercial and investigator led clinical trials of novel compounds in ALS. Much of our clinical research is supported by the charity Research Motor Neurone.

Contact
Location
School of Medicine, Trinity Biomedical Sciences Institute, Pearse Street, Dublin 2, Dublin, Ireland

Our Specialists

Orla Hardiman

Professor of Neurology

Professor Hardiman trained in Neurology in Boston prior to her appointment as […]

Orla Hardiman
Current trials
Active
Phase ii

RT001 in Amyotrophic Lateral Sclerosis

Industry trial
In this phase 2 trial, we will study the safety and efficacy of the compound RT001 in people living with ALS. This clinical trial is sponsored by Retrotope Inc.
Read more
Active
Phase iii

ALXN1210-ALS-308 trial

Industry trial
This phase 3 trial aims to study the safety and efficacy of the drug ‘ravulizumab’ in people living with ALS. To register for this study, you should contact your local ALS centre or treating physician.
Read more
Active
Phase iii

VALOR study

Industry trial
Biogen is conducting a clinical trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS) with a SOD1 gene mutation.
Read more
Recruiting
Phase iii

TUDCA-ALS

Investigator initiated trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more